ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,590 | -35.3% | 127,000 | +1.4% | 0.00% | -33.3% |
| Q2 2023 | $622,244 | +22.9% | 125,200 | +22.1% | 0.01% | +20.0% |
| Q1 2023 | $506,350 | +72.4% | 102,500 | +119.5% | 0.01% | +66.7% |
| Q4 2022 | $293,743 | +24.2% | 46,700 | +113.2% | 0.00% | 0.0% |
| Q3 2022 | $236,520 | +109.3% | 21,900 | +76.6% | 0.00% | +200.0% |
| Q1 2022 | $113,000 | -54.6% | 12,400 | +27.8% | 0.00% | -66.7% |
| Q3 2021 | $249,000 | -2.7% | 9,700 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $256,000 | – | 9,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |